Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04966663
Title Using ctDNA to Determine Therapies for Lung Cancer (ctDNA Lung RCT)
Recruitment Not yet recruiting
Gender
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Nivolumab + Pemetrexed Disodium

Cisplatin + Gemcitabine + Nivolumab

Cisplatin + Nivolumab + Pemetrexed Disodium

Carboplatin + Gemcitabine + Nivolumab

Age Groups: senior | adult
Covered Countries CAN


No variant requirements are available.